Neurocrine Biosciences (NBIX) Operating Margin (2010 - 2026)
Neurocrine Biosciences (NBIX) operating margin from Jun 30, 2010 to Mar 31, 2026. The current Neurocrine Biosciences (NBIX) operating margin is 23.74%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Neurocrine Biosciences (NBIX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 21.64% | -10.65% |
| 2024 | 24.22% | +82.18% |
| 2023 | 13.30% | -20.51% |
| 2022 | 16.73% | +84.97% |
| 2021 | 9.04% | -41.98% |
| 2020 | 15.58% | +69.88% |
| 2019 | 9.17% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 8.16% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | -81.27% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | -982.47% | N/A |
| 2016 | 0.00% | -100.00% |
| 2015 | -476.48% | N/A |
| 2015 | 0.00% | -100.00% |
| 2013 | -1701.37% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | -100.00% |
| 2012 | 2.73% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | -100.00% |
| 2011 | 43.82% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | -100.00% |
| 2010 | -40.96% | -97.75% |
| 2009 | -1819.32% | N/A |
Comparison Neurocrine Biosciences (NBIX) operating margin with competitors
Neurocrine Biosciences (NBIX) operating margin is 23.74%.